Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 2—February 2014

Volume 20, Number 2—February 2014   PDF Version [PDF - 8.97 MB - 179 pages]

Synopses

  • Poxvirus Viability and Signatures in Historical Relics PDF Version[PDF - 419 KB - 8 pages]
    A. M. McCollum et al.
        View Abstract

    Although it has been >30 years since the eradication of smallpox, the unearthing of well-preserved tissue material in which the virus may reside has called into question the viability of variola virus decades or centuries after its original occurrence. Experimental data to address the long-term stability and viability of the virus are limited. There are several instances of well-preserved corpses and tissues that have been examined for poxvirus viability and viral DNA. These historical specimens cause concern for potential exposures, and each situation should be approached cautiously and independently with the available information. Nevertheless, these specimens provide information on the history of a major disease and vaccination against it.

     Length: 0:52
        Cite This Article
    EID McCollum AM, Li Y, Wilkins K, Karem KL, Davidson WB, Paddock CD, et al. Poxvirus Viability and Signatures in Historical Relics. Emerg Infect Dis. 2014;20(2):177-184. https://dx.doi.org/10.3201/eid2002.131098
    AMA McCollum AM, Li Y, Wilkins K, et al. Poxvirus Viability and Signatures in Historical Relics. Emerging Infectious Diseases. 2014;20(2):177-184. doi:10.3201/eid2002.131098.
    APA McCollum, A. M., Li, Y., Wilkins, K., Karem, K. L., Davidson, W. B., Paddock, C. D....Damon, I. K. (2014). Poxvirus Viability and Signatures in Historical Relics. Emerging Infectious Diseases, 20(2), 177-184. https://dx.doi.org/10.3201/eid2002.131098.
        Email Email this Article
  • Anncaliia algerae Microsporidial Myositis PDF Version[PDF - 441 KB - 7 pages]
    M. R. Watts et al.
        View Abstract

    The insect microsporidian Anncaliia algerae was first described in 2004 as a cause of fatal myositis in an immunosuppressed person from Pennsylvania, USA. Two cases were subsequently reported, and we detail 2 additional cases, including the only nonfatal case. We reviewed all 5 case histories with respect to clinical characteristics, diagnosis, and management and summarized organism life cycle and epidemiology. Before infection, all case-patients were using immunosuppressive medications for rheumatoid arthritis or solid-organ transplantation. Four of the 5 case-patients were from Australia. All diagnoses were confirmed by skeletal muscle biopsy; however, peripheral nerves and other tissues may be infected. The surviving patient received albendazole and had a reduction of immunosuppressive medications and measures to prevent complications. Although insects are the natural hosts for A. algerae, human contact with water contaminated by spores may be a mode of transmission. A. algerae has emerged as a cause of myositis, particularly in coastal Australia.

     Length: 1:30
        Cite This Article
    EID Watts MR, Chan R, Cheong E, Brammah S, Clezy KR, Tong C, et al. Anncaliia algerae Microsporidial Myositis. Emerg Infect Dis. 2014;20(2):185-191. https://dx.doi.org/10.3201/eid2002.131126
    AMA Watts MR, Chan R, Cheong E, et al. Anncaliia algerae Microsporidial Myositis. Emerging Infectious Diseases. 2014;20(2):185-191. doi:10.3201/eid2002.131126.
    APA Watts, M. R., Chan, R., Cheong, E., Brammah, S., Clezy, K. R., Tong, C....Reddel, S. W. (2014). Anncaliia algerae Microsporidial Myositis. Emerging Infectious Diseases, 20(2), 185-191. https://dx.doi.org/10.3201/eid2002.131126.
        Email Email this Article

Research

  • Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo PDF Version[PDF - 552 KB - 8 pages]
    J. R. Kugelman et al.
        View Abstract

    Monkeypox virus is a zoonotic virus endemic to Central Africa. Although active disease surveillance has assessed monkeypox disease prevalence and geographic range, information about virus diversity is lacking. We therefore assessed genome diversity of viruses in 60 samples obtained from humans with primary and secondary cases of infection from 2005 through 2007. We detected 4 distinct lineages and a deletion that resulted in gene loss in 10 (16.7%) samples and that seemed to correlate with human-to-human transmission (p = 0.0544). The data suggest a high frequency of spillover events from the pool of viruses in nonhuman animals, active selection through genomic destabilization and gene loss, and increased disease transmissibility and severity. The potential for accelerated adaptation to humans should be monitored through improved surveillance.

     Length: 1:11
        Cite This Article
    EID Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, et al. Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo. Emerg Infect Dis. 2014;20(2):232-239. https://dx.doi.org/10.3201/eid2002.130118
    AMA Kugelman JR, Johnston SC, Mulembakani PM, et al. Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo. Emerging Infectious Diseases. 2014;20(2):232-239. doi:10.3201/eid2002.130118.
    APA Kugelman, J. R., Johnston, S. C., Mulembakani, P. M., Kisalu, N., Lee, M. S., Koroleva, G....Rimoin, A. W. (2014). Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo. Emerging Infectious Diseases, 20(2), 232-239. https://dx.doi.org/10.3201/eid2002.130118.
        Email Email this Article
  • Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013 PDF Version[PDF - 546 KB - 9 pages]
    L. Guo et al.
        View Abstract

    Understanding host antibody response is crucial for predicting disease severity and for vaccine development. We investigated antibody responses against influenza A(H7N9) virus in 48 serum samples from 21 patients, including paired samples from 15 patients. IgG against subtype H7 and neutralizing antibodies (NAbs) were not detected in acute-phase samples, but ELISA geometric mean titers increased in convalescent-phase samples; NAb titers were 20–80 (geometric mean titer 40). Avidity to IgG against subtype H7 was significantly lower than that against H1 and H3. IgG against H3 was boosted after infection with influenza A(H7N9) virus, and its level in acute-phase samples correlated with that against H7 in convalescent-phase samples. A correlation was also found between hemagglutinin inhibition and NAb titers and between hemagglutinin inhibition and IgG titers against H7. Because of the relatively weak protective antibody response to influenza A(H7N9), multiple vaccinations might be needed to achieve protective immunity.

     Length: 1:45
        Cite This Article
    EID Guo L, Zhang X, Ren L, Yu X, Chen L, Zhou H, et al. Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013. Emerg Infect Dis. 2014;20(2):192-200. https://dx.doi.org/10.3201/eid2002.131094
    AMA Guo L, Zhang X, Ren L, et al. Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013. Emerging Infectious Diseases. 2014;20(2):192-200. doi:10.3201/eid2002.131094.
    APA Guo, L., Zhang, X., Ren, L., Yu, X., Chen, L., Zhou, H....Wang, J. (2014). Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013. Emerging Infectious Diseases, 20(2), 192-200. https://dx.doi.org/10.3201/eid2002.131094.
        Email Email this Article
  • Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children PDF Version[PDF - 6.49 MB - 10 pages]
    G. Biesbroek et al.
        View Abstract

    Seven-valent pneumococcal conjugate vaccine (PCV-7) is effective against vaccine serotype disease and carriage. Nevertheless, shifts in colonization and disease toward nonvaccine serotypes and other potential pathogens have been described. To understand the extent of these shifts, we analyzed nasopharyngeal microbial profiles of 97 PCV-7–vaccinated infants and 103 control infants participating in a randomized controlled trial in the Netherlands. PCV-7 immunization resulted in a temporary shift in microbial community composition and increased bacterial diversity. Immunization also resulted in decreased presence of the pneumococcal vaccine serotype and an increase in the relative abundance and presence of nonpneumococcal streptococci and anaerobic bacteria. Furthermore, the abundance of Haemophilus and Staphylococcus bacteria in vaccinees was increased over that in controls. This study illustrates the much broader effect of vaccination with PCV-7 on the microbial community than currently assumed, and highlights the need for careful monitoring when implementing vaccines directed against common colonizers.

     Length: 1:39
        Cite This Article
    EID Biesbroek G, Wang X, Keijser B, Eijkemans R, Trzciński K, Rots NY, et al. Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children. Emerg Infect Dis. 2014;20(2):201-210. https://dx.doi.org/10.3201/eid2002.131220
    AMA Biesbroek G, Wang X, Keijser B, et al. Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children. Emerging Infectious Diseases. 2014;20(2):201-210. doi:10.3201/eid2002.131220.
    APA Biesbroek, G., Wang, X., Keijser, B., Eijkemans, R., Trzciński, K., Rots, N. Y....Bogaert, D. (2014). Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children. Emerging Infectious Diseases, 20(2), 201-210. https://dx.doi.org/10.3201/eid2002.131220.
        Email Email this Article
  • Fungal Endophthalmitis Associated with Compounded Products PDF Version[PDF - 1.10 MB - 9 pages]
    C. A. Mikosz et al.
        View Abstract

    Fungal endophthalmitis is a rare but serious infection. In March 2012, several cases of probable and laboratory-confirmed fungal endophthalmitis occurring after invasive ocular procedures were reported nationwide. We identified 47 cases in 9 states: 21 patients had been exposed to the intraocular dye Brilliant Blue G (BBG) during retinal surgery, and the other 26 had received an intravitreal injection containing triamcinolone acetonide. Both drugs were produced by Franck’s Compounding Lab (Ocala, FL, USA). Fusarium incarnatum-equiseti species complex mold was identified in specimens from BBG-exposed case-patients and an unopened BBG vial. Bipolaris hawaiiensis mold was identified in specimens from triamcinolone-exposed case-patients. Exposure to either product was the only factor associated with case status. Of 40 case-patients for whom data were available, 39 (98%) lost vision. These concurrent outbreaks, associated with 1 compounding pharmacy, resulted in a product recall. Ensuring safety and integrity of compounded medications is critical for preventing further outbreaks associated with compounded products.

     Length: 1:42
        Cite This Article
    EID Mikosz CA, Smith RM, Kim M, Tyson C, Lee EH, Adams E, et al. Fungal Endophthalmitis Associated with Compounded Products. Emerg Infect Dis. 2014;20(2):248-256. https://dx.doi.org/10.3201/eid2002.131257
    AMA Mikosz CA, Smith RM, Kim M, et al. Fungal Endophthalmitis Associated with Compounded Products. Emerging Infectious Diseases. 2014;20(2):248-256. doi:10.3201/eid2002.131257.
    APA Mikosz, C. A., Smith, R. M., Kim, M., Tyson, C., Lee, E. H., Adams, E....Park, B. J. (2014). Fungal Endophthalmitis Associated with Compounded Products. Emerging Infectious Diseases, 20(2), 248-256. https://dx.doi.org/10.3201/eid2002.131257.
        Email Email this Article
  • Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA PDF Version[PDF - 506 KB - 7 pages]
    M. A. Diuk-Wasser et al.
        View Abstract

    Human babesiosis is an emerging tick-borne disease caused by the intraerythrocytic protozoan Babesia microti. Its geographic distribution is more limited than that of Lyme disease, despite sharing the same tick vector and reservoir hosts. The geographic range of babesiosis is expanding, but knowledge of its range is incomplete and relies exclusively on reports of human cases. We evaluated the utility of tick-based surveillance for monitoring disease expansion by comparing the ratios of the 2 infections in humans and ticks in areas with varying B. microti endemicity. We found a close association between human disease and tick infection ratios in long-established babesiosis-endemic areas but a lower than expected incidence of human babesiosis on the basis of tick infection rates in new disease-endemic areas. This finding suggests that babesiosis at emerging sites is underreported. Vector-based surveillance can provide an early warning system for the emergence of human babesiosis.

     Length: 1:24
        Cite This Article
    EID Diuk-Wasser MA, Liu Y, Steeves TK, Folsom-O’Keefe C, Dardick KR, Lepore T, et al. Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA. Emerg Infect Dis. 2014;20(2):225-231. https://dx.doi.org/10.3201/eid2002.130644
    AMA Diuk-Wasser MA, Liu Y, Steeves TK, et al. Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA. Emerging Infectious Diseases. 2014;20(2):225-231. doi:10.3201/eid2002.130644.
    APA Diuk-Wasser, M. A., Liu, Y., Steeves, T. K., Folsom-O’Keefe, C., Dardick, K. R., Lepore, T....Krause, P. J. (2014). Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA. Emerging Infectious Diseases, 20(2), 225-231. https://dx.doi.org/10.3201/eid2002.130644.
        Email Email this Article
  • Lymphocytic Choriomeningitis Virus in Employees and Mice at Multipremises Feeder-Rodent Operation, United States, 2012 PDF Version[PDF - 583 KB - 8 pages]
    B. Knust et al.
        View Abstract

    We investigated the extent of lymphocytic choriomeningitis virus (LCMV) infection in employees and rodents at 3 commercial breeding facilities. Of 97 employees tested, 31 (32%) had IgM and/or IgG to LCMV, and aseptic meningitis was diagnosed in 4 employees. Of 1,820 rodents tested in 1 facility, 382 (21%) mice (Mus musculus) had detectable IgG, and 13 (0.7%) were positive by reverse transcription PCR; LCMV was isolated from 8. Rats (Rattus norvegicus) were not found to be infected. S-segment RNA sequence was similar to strains previously isolated in North America. Contact by wild mice with colony mice was the likely source for LCMV, and shipments of infected mice among facilities spread the infection. The breeding colonies were depopulated to prevent further human infections. Future outbreaks can be prevented with monitoring and management, and employees should be made aware of LCMV risks and prevention.

     Length: 1:42
        Cite This Article
    EID Knust B, Ströher U, Edison L, Albariño CG, Lovejoy J, Armeanu E, et al. Lymphocytic Choriomeningitis Virus in Employees and Mice at Multipremises Feeder-Rodent Operation, United States, 2012. Emerg Infect Dis. 2014;20(2):240-247. https://dx.doi.org/10.3201/eid2002.130860
    AMA Knust B, Ströher U, Edison L, et al. Lymphocytic Choriomeningitis Virus in Employees and Mice at Multipremises Feeder-Rodent Operation, United States, 2012. Emerging Infectious Diseases. 2014;20(2):240-247. doi:10.3201/eid2002.130860.
    APA Knust, B., Ströher, U., Edison, L., Albariño, C. G., Lovejoy, J., Armeanu, E....Rollin, P. E. (2014). Lymphocytic Choriomeningitis Virus in Employees and Mice at Multipremises Feeder-Rodent Operation, United States, 2012. Emerging Infectious Diseases, 20(2), 240-247. https://dx.doi.org/10.3201/eid2002.130860.
        Email Email this Article
  • Subtyping Cryptosporidium ubiquitum,a Zoonotic Pathogen Emerging in Humans PDF Version[PDF - 643 KB - 8 pages]
    N. Li et al.
        View Abstract

    Cryptosporidium ubiquitum is an emerging zoonotic pathogen. In the past, it was not possible to identify an association between cases of human and animal infection. We conducted a genomic survey of the species, developed a subtyping tool targeting the 60-kDa glycoprotein (gp60) gene, and identified 6 subtype families (XIIa–XIIf) of C. ubiquitum. Host adaptation was apparent at the gp60 locus; subtype XIIa was found in ruminants worldwide, subtype families XIIb–XIId were found in rodents in the United States, and XIIe and XIIf were found in rodents in the Slovak Republic. Humans in the United States were infected with isolates of subtypes XIIb–XIId, whereas those in other areas were infected primarily with subtype XIIa isolates. In addition, subtype families XIIb and XIId were detected in drinking source water in the United States. Contact with C. ubiquitum–infected sheep and drinking water contaminated by infected wildlife could be sources of human infections.

     Length: 1:40
        Cite This Article
    EID Li N, Xiao L, Alderisio K, Elwin K, Cebelinski E, Chalmers R, et al. Subtyping Cryptosporidium ubiquitum,a Zoonotic Pathogen Emerging in Humans. Emerg Infect Dis. 2014;20(2):217-224. https://dx.doi.org/10.3201/eid2002.121797
    AMA Li N, Xiao L, Alderisio K, et al. Subtyping Cryptosporidium ubiquitum,a Zoonotic Pathogen Emerging in Humans. Emerging Infectious Diseases. 2014;20(2):217-224. doi:10.3201/eid2002.121797.
    APA Li, N., Xiao, L., Alderisio, K., Elwin, K., Cebelinski, E., Chalmers, R....Feng, Y. (2014). Subtyping Cryptosporidium ubiquitum,a Zoonotic Pathogen Emerging in Humans. Emerging Infectious Diseases, 20(2), 217-224. https://dx.doi.org/10.3201/eid2002.121797.
        Email Email this Article
  • Novel Paramyxovirus Associated with Severe Acute Febrile Disease, South Sudan and Uganda, 2012 PDF Version[PDF - 539 KB - 6 pages]
    C. G. Albariño et al.
        View Abstract

    In 2012, a female wildlife biologist experienced fever, malaise, headache, generalized myalgia and arthralgia, neck stiffness, and a sore throat shortly after returning to the United States from a 6-week field expedition to South Sudan and Uganda. She was hospitalized, after which a maculopapular rash developed and became confluent. When the patient was discharged from the hospital on day 14, arthralgia and myalgia had improved, oropharynx ulcerations had healed, the rash had resolved without desquamation, and blood counts and hepatic enzyme levels were returning to reference levels. After several known suspect pathogens were ruled out as the cause of her illness, deep sequencing and metagenomics analysis revealed a novel paramyxovirus related to rubula-like viruses isolated from fruit bats.

     Length: 1:15
        Cite This Article
    EID Albariño CG, Foltzer M, Towner JS, Rowe LA, Campbell S, Jaramillo CM, et al. Novel Paramyxovirus Associated with Severe Acute Febrile Disease, South Sudan and Uganda, 2012. Emerg Infect Dis. 2014;20(2):211-216. https://dx.doi.org/10.3201/eid2002.131620
    AMA Albariño CG, Foltzer M, Towner JS, et al. Novel Paramyxovirus Associated with Severe Acute Febrile Disease, South Sudan and Uganda, 2012. Emerging Infectious Diseases. 2014;20(2):211-216. doi:10.3201/eid2002.131620.
    APA Albariño, C. G., Foltzer, M., Towner, J. S., Rowe, L. A., Campbell, S., Jaramillo, C. M....Ströher, U. (2014). Novel Paramyxovirus Associated with Severe Acute Febrile Disease, South Sudan and Uganda, 2012. Emerging Infectious Diseases, 20(2), 211-216. https://dx.doi.org/10.3201/eid2002.131620.
        Email Email this Article

Dispatches

  • Melioidosis Caused by Burkholderia pseudomallei in Drinking Water, Thailand, 2012 PDF Version[PDF - 346 KB - 4 pages]
    D. Limmathurotsakul et al.
        View Abstract

    We identified 10 patients in Thailand with culture-confirmed melioidosis who had Burkholderia pseudomallei isolated from their drinking water. The multilocus sequence type of B. pseudomallei from clinical specimens and water samples were identical for 2 patients. This finding suggests that drinking water is a preventable source of B. pseudomallei infection.

        Cite This Article
    EID Limmathurotsakul D, Wongsuvan G, Aanensen D, Ngamwilai S, Saiprom N, Rongkard P, et al. Melioidosis Caused by Burkholderia pseudomallei in Drinking Water, Thailand, 2012. Emerg Infect Dis. 2014;20(2):265-268. https://dx.doi.org/10.3201/eid2002.121891
    AMA Limmathurotsakul D, Wongsuvan G, Aanensen D, et al. Melioidosis Caused by Burkholderia pseudomallei in Drinking Water, Thailand, 2012. Emerging Infectious Diseases. 2014;20(2):265-268. doi:10.3201/eid2002.121891.
    APA Limmathurotsakul, D., Wongsuvan, G., Aanensen, D., Ngamwilai, S., Saiprom, N., Rongkard, P....Peacock, S. J. (2014). Melioidosis Caused by Burkholderia pseudomallei in Drinking Water, Thailand, 2012. Emerging Infectious Diseases, 20(2), 265-268. https://dx.doi.org/10.3201/eid2002.121891.
        Email Email this Article
  • Genetic Characterization of Coronaviruses from Domestic Ferrets, Japan PDF Version[PDF - 514 KB - 4 pages]
    Y. Terada et al.
        View Abstract

    We detected ferret coronaviruses in 44 (55.7%) of 79 pet ferrets tested in Japan and classified the viruses into 2 genotypes on the basis of genotype-specific PCR. Our results show that 2 ferret coronaviruses that cause feline infectious peritonitis–like disease and epizootic catarrhal enteritis are enzootic among ferrets in Japan.

        Cite This Article
    EID Terada Y, Minami S, Noguchi K, Mahmoud H, Shimoda H, Mochizuki M, et al. Genetic Characterization of Coronaviruses from Domestic Ferrets, Japan. Emerg Infect Dis. 2014;20(2):284-287. https://dx.doi.org/10.3201/eid2002.130543
    AMA Terada Y, Minami S, Noguchi K, et al. Genetic Characterization of Coronaviruses from Domestic Ferrets, Japan. Emerging Infectious Diseases. 2014;20(2):284-287. doi:10.3201/eid2002.130543.
    APA Terada, Y., Minami, S., Noguchi, K., Mahmoud, H., Shimoda, H., Mochizuki, M....Maeda, K. (2014). Genetic Characterization of Coronaviruses from Domestic Ferrets, Japan. Emerging Infectious Diseases, 20(2), 284-287. https://dx.doi.org/10.3201/eid2002.130543.
        Email Email this Article
  • Reemergence of Rift Valley Fever, Mauritania, 2010 PDF Version[PDF - 436 KB - 4 pages]
    O. Faye et al.
        View Abstract

    A Rift Valley fever (RVF) outbreak in humans and animals occurred in Mauritania in 2010. Thirty cases of RVF in humans and 3 deaths were identified. RVFV isolates were recovered from humans, camels, sheep, goats, and Culex antennatus mosquitoes. Phylogenetic analysis of isolates indicated a virus origin from western Africa.

        Cite This Article
    EID Faye O, Ba H, Ba Y, Freire C, Faye O, Ndiaye O, et al. Reemergence of Rift Valley Fever, Mauritania, 2010. Emerg Infect Dis. 2014;20(2):300-303. https://dx.doi.org/10.3201/eid2002.130996
    AMA Faye O, Ba H, Ba Y, et al. Reemergence of Rift Valley Fever, Mauritania, 2010. Emerging Infectious Diseases. 2014;20(2):300-303. doi:10.3201/eid2002.130996.
    APA Faye, O., Ba, H., Ba, Y., Freire, C., Faye, O., Ndiaye, O....Sall, A. A. (2014). Reemergence of Rift Valley Fever, Mauritania, 2010. Emerging Infectious Diseases, 20(2), 300-303. https://dx.doi.org/10.3201/eid2002.130996.
        Email Email this Article
  • Rift Valley Fever Outbreak, Southern Mauritania, 2012 PDF Version[PDF - 379 KB - 4 pages]
    A. Sow et al.
        View Abstract

    After a period of heavy rainfall, an outbreak of Rift Valley fever occurred in southern Mauritania during September–November 2012. A total of 41 human cases were confirmed, including 13 deaths, and 12 Rift Valley fever virus strains were isolated. Moudjeria and Temchecket Departments were the most affected areas.

        Cite This Article
    EID Sow A, Faye O, Ba Y, Ba H, Diallo D, Faye O, et al. Rift Valley Fever Outbreak, Southern Mauritania, 2012. Emerg Infect Dis. 2014;20(2):296-299. https://dx.doi.org/10.3201/eid2002.131000
    AMA Sow A, Faye O, Ba Y, et al. Rift Valley Fever Outbreak, Southern Mauritania, 2012. Emerging Infectious Diseases. 2014;20(2):296-299. doi:10.3201/eid2002.131000.
    APA Sow, A., Faye, O., Ba, Y., Ba, H., Diallo, D., Faye, O....Sall, A. (2014). Rift Valley Fever Outbreak, Southern Mauritania, 2012. Emerging Infectious Diseases, 20(2), 296-299. https://dx.doi.org/10.3201/eid2002.131000.
        Email Email this Article
  • Co-circulation of West Nile Virus Variants, Arizona, USA, 2010 PDF Version[PDF - 417 KB - 4 pages]
    J. A. Plante et al.
        View Abstract

    Molecular analysis of West Nile virus (WNV) isolates obtained during a 2010 outbreak in Maricopa County, Arizona, USA, demonstrated co-circulation of 3 distinct genetic variants, including strains with novel envelope protein mutations. These results highlight the continuing evolution of WNV in North America and the current complexity of WNV dispersal and transmission.

        Cite This Article
    EID Plante JA, Burkhalter KL, Mann BR, Godsey MS, Mutebi J, Beasley D. Co-circulation of West Nile Virus Variants, Arizona, USA, 2010. Emerg Infect Dis. 2014;20(2):272-275. https://dx.doi.org/10.3201/eid2002.131008
    AMA Plante JA, Burkhalter KL, Mann BR, et al. Co-circulation of West Nile Virus Variants, Arizona, USA, 2010. Emerging Infectious Diseases. 2014;20(2):272-275. doi:10.3201/eid2002.131008.
    APA Plante, J. A., Burkhalter, K. L., Mann, B. R., Godsey, M. S., Mutebi, J., & Beasley, D. (2014). Co-circulation of West Nile Virus Variants, Arizona, USA, 2010. Emerging Infectious Diseases, 20(2), 272-275. https://dx.doi.org/10.3201/eid2002.131008.
        Email Email this Article
  • Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru PDF Version[PDF - 347 KB - 4 pages]
    H. Razuri et al.
        View Abstract

    We investigated hantaviruses in rodents in the southern Amazon Basin of Peru and identified an Andes virus variant from Neacomys spinosus mice. This finding extends the known range of this virus in South America and the range of recognized hantaviruses in Peru. Further studies of the epizoology of hantaviruses in this region are warranted.

        Cite This Article
    EID Razuri H, Tokarz R, Ghersi BM, Salmon-Mulanovich G, Guezala M, Albujar C, et al. Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru. Emerg Infect Dis. 2014;20(2):257-260. https://dx.doi.org/10.3201/eid2002.131418
    AMA Razuri H, Tokarz R, Ghersi BM, et al. Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru. Emerging Infectious Diseases. 2014;20(2):257-260. doi:10.3201/eid2002.131418.
    APA Razuri, H., Tokarz, R., Ghersi, B. M., Salmon-Mulanovich, G., Guezala, M., Albujar, C....Montgomery, J. M. (2014). Andes Hantavirus Variant in Rodents, Southern Amazon Basin, Peru. Emerging Infectious Diseases, 20(2), 257-260. https://dx.doi.org/10.3201/eid2002.131418.
        Email Email this Article
  • Crimean-Congo Hemorrhagic Fever Virus, Greece PDF Version[PDF - 325 KB - 3 pages]
    A. Papa et al.
        View Abstract

    Seroprevalence of Crimean-Congo hemorrhagic fever virus (CCHFV) is high in some regions of Greece, but only 1 case of disease has been reported. We used 4 methods to test 118 serum samples that were positive for CCHFV IgG by commercial ELISA and confirmed the positive results. A nonpathogenic or low-pathogenicity strain may be circulating.

        Cite This Article
    EID Papa A, Sidira P, Larichev V, Gavrilova L, Kuzmina K, Mousavi-Jazi M, et al. Crimean-Congo Hemorrhagic Fever Virus, Greece. Emerg Infect Dis. 2014;20(2):288-290. https://dx.doi.org/10.3201/eid2002.130690
    AMA Papa A, Sidira P, Larichev V, et al. Crimean-Congo Hemorrhagic Fever Virus, Greece. Emerging Infectious Diseases. 2014;20(2):288-290. doi:10.3201/eid2002.130690.
    APA Papa, A., Sidira, P., Larichev, V., Gavrilova, L., Kuzmina, K., Mousavi-Jazi, M....Nichol, S. (2014). Crimean-Congo Hemorrhagic Fever Virus, Greece. Emerging Infectious Diseases, 20(2), 288-290. https://dx.doi.org/10.3201/eid2002.130690.
        Email Email this Article
  • Lethal Factor and Anti-Protective Antigen IgG Levels Associated with Inhalation Anthrax, Minnesota, USA PDF Version[PDF - 577 KB - 5 pages]
    M. D. Sprenkle et al.
        View Abstract

    Bacillus anthracis was identified in a 61-year-old man hospitalized in Minnesota, USA. Cooperation between the hospital and the state health agency enhanced prompt identification of the pathogen. Treatment comprising antimicrobial drugs, anthrax immune globulin, and pleural drainage led to full recovery; however, the role of passive immunization in anthrax treatment requires further evaluation.

        Cite This Article
    EID Sprenkle MD, Griffith J, Marinelli W, Boyer AE, Quinn CP, Pesik NT, et al. Lethal Factor and Anti-Protective Antigen IgG Levels Associated with Inhalation Anthrax, Minnesota, USA. Emerg Infect Dis. 2014;20(2):310-314. https://dx.doi.org/10.3201/eid2002.130245
    AMA Sprenkle MD, Griffith J, Marinelli W, et al. Lethal Factor and Anti-Protective Antigen IgG Levels Associated with Inhalation Anthrax, Minnesota, USA. Emerging Infectious Diseases. 2014;20(2):310-314. doi:10.3201/eid2002.130245.
    APA Sprenkle, M. D., Griffith, J., Marinelli, W., Boyer, A. E., Quinn, C. P., Pesik, N. T....Blaney, D. D. (2014). Lethal Factor and Anti-Protective Antigen IgG Levels Associated with Inhalation Anthrax, Minnesota, USA. Emerging Infectious Diseases, 20(2), 310-314. https://dx.doi.org/10.3201/eid2002.130245.
        Email Email this Article
  • Replicative Capacity of MERS Coronavirus in Livestock Cell Lines PDF Version[PDF - 422 KB - 4 pages]
    I. Eckerle et al.
        View Abstract

    Replicative capacity of Middle East respiratory syndrome coronavirus (MERS-CoV) was assessed in cell lines derived from livestock and peridomestic small mammals on the Arabian Peninsula. Only cell lines originating from goats and camels showed efficient replication of MERS-CoV. These results provide direction in the search for the intermediate host of MERS-CoV.

        Cite This Article
    EID Eckerle I, Corman VM, Müller MA, Lenk M, Ulrich RG, Drosten C. Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerg Infect Dis. 2014;20(2):276-279. https://dx.doi.org/10.3201/eid2002.131182
    AMA Eckerle I, Corman VM, Müller MA, et al. Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerging Infectious Diseases. 2014;20(2):276-279. doi:10.3201/eid2002.131182.
    APA Eckerle, I., Corman, V. M., Müller, M. A., Lenk, M., Ulrich, R. G., & Drosten, C. (2014). Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerging Infectious Diseases, 20(2), 276-279. https://dx.doi.org/10.3201/eid2002.131182.
        Email Email this Article
  • Investigation of Inhalation Anthrax Case, United States PDF Version[PDF - 350 KB - 4 pages]
    J. Griffith et al.
        View Abstract

    Inhalation anthrax occurred in a man who vacationed in 4 US states where anthrax is enzootic. Despite an extensive multi-agency investigation, the specific source was not detected, and no additional related human or animal cases were found. Although rare, inhalation anthrax can occur naturally in the United States.

        Cite This Article
    EID Griffith J, Blaney D, Shadomy S, Lehman M, Pesik N, Tostenson S, et al. Investigation of Inhalation Anthrax Case, United States. Emerg Infect Dis. 2014;20(2):280-283. https://dx.doi.org/10.3201/eid2002.130021
    AMA Griffith J, Blaney D, Shadomy S, et al. Investigation of Inhalation Anthrax Case, United States. Emerging Infectious Diseases. 2014;20(2):280-283. doi:10.3201/eid2002.130021.
    APA Griffith, J., Blaney, D., Shadomy, S., Lehman, M., Pesik, N., Tostenson, S....Lynfield, R. (2014). Investigation of Inhalation Anthrax Case, United States. Emerging Infectious Diseases, 20(2), 280-283. https://dx.doi.org/10.3201/eid2002.130021.
        Email Email this Article
  • Burkholderia pseudomallei Isolates in 2 Pet Iguanas, California, USA PDF Version[PDF - 383 KB - 3 pages]
    A. M. Zehnder et al.
        View Abstract

    Burkholderia pseudomallei, the causative agent of melioidosis, was isolated from abscesses of 2 pet green iguanas in California, USA. The international trade in iguanas may contribute to importation of this pathogen into countries where it is not endemic and put persons exposed to these animals at risk for infection.

        Cite This Article
    EID Zehnder AM, Hawkins MG, Koski MA, Lifland B, Byrne BA, Swanson AA, et al. Burkholderia pseudomallei Isolates in 2 Pet Iguanas, California, USA. Emerg Infect Dis. 2014;20(2):304-306. https://dx.doi.org/10.3201/eid2002.131314
    AMA Zehnder AM, Hawkins MG, Koski MA, et al. Burkholderia pseudomallei Isolates in 2 Pet Iguanas, California, USA. Emerging Infectious Diseases. 2014;20(2):304-306. doi:10.3201/eid2002.131314.
    APA Zehnder, A. M., Hawkins, M. G., Koski, M. A., Lifland, B., Byrne, B. A., Swanson, A. A....Beeler, E. S. (2014). Burkholderia pseudomallei Isolates in 2 Pet Iguanas, California, USA. Emerging Infectious Diseases, 20(2), 304-306. https://dx.doi.org/10.3201/eid2002.131314.
        Email Email this Article
  • Molecular Detection of Diphyllobothrium nihonkaiense in Humans, China PDF Version[PDF - 385 KB - 4 pages]
    S. Chen et al.
        View Abstract

    The cause of diphyllobothriosis in 5 persons in Harbin and Shanghai, China, during 2008–2011, initially attributed to the tapeworm Diphyllobothrium latum, was confirmed as D. nihonkaiense by using molecular analysis of expelled proglottids. The use of morphologic characteristics alone to identify this organism was inadequate and led to misidentification of the species.

        Cite This Article
    EID Chen S, Ai L, Zhang Y, Chen J, Zhang W, Li Y, et al. Molecular Detection of Diphyllobothrium nihonkaiense in Humans, China. Emerg Infect Dis. 2014;20(2):315-318. https://dx.doi.org/10.3201/eid2002.121889
    AMA Chen S, Ai L, Zhang Y, et al. Molecular Detection of Diphyllobothrium nihonkaiense in Humans, China. Emerging Infectious Diseases. 2014;20(2):315-318. doi:10.3201/eid2002.121889.
    APA Chen, S., Ai, L., Zhang, Y., Chen, J., Zhang, W., Li, Y....Yamasaki, H. (2014). Molecular Detection of Diphyllobothrium nihonkaiense in Humans, China. Emerging Infectious Diseases, 20(2), 315-318. https://dx.doi.org/10.3201/eid2002.121889.
        Email Email this Article
  • Human Cutaneous Anthrax, Georgia 2010–2012 PDF Version[PDF - 486 KB - 4 pages]
    I. Kracalik et al.
        View Abstract

    We assessed the occurrence of human cutaneous anthrax in Georgia during 2010–-2012 by examining demographic and spatial characteristics of reported cases. Reporting increased substantially, as did clustering of cases near urban centers. Control efforts, including education about anthrax and livestock vaccination, can be directed at areas of high risk.

        Cite This Article
    EID Kracalik I, Malania L, Tsertsvadze N, Manvelyan J, Bakanidze L, Imnadze P, et al. Human Cutaneous Anthrax, Georgia 2010–2012. Emerg Infect Dis. 2014;20(2):261-264. https://dx.doi.org/10.3201/eid2002.130522
    AMA Kracalik I, Malania L, Tsertsvadze N, et al. Human Cutaneous Anthrax, Georgia 2010–2012. Emerging Infectious Diseases. 2014;20(2):261-264. doi:10.3201/eid2002.130522.
    APA Kracalik, I., Malania, L., Tsertsvadze, N., Manvelyan, J., Bakanidze, L., Imnadze, P....Blackburn, J. K. (2014). Human Cutaneous Anthrax, Georgia 2010–2012. Emerging Infectious Diseases, 20(2), 261-264. https://dx.doi.org/10.3201/eid2002.130522.
        Email Email this Article
  • Fatal Systemic Morbillivirus Infection in Bottlenose Dolphin, Canary Islands, Spain PDF Version[PDF - 308 KB - 3 pages]
    E. Sierra et al.
        View Abstract

    A systemic morbillivirus infection was diagnosed postmortem in a juvenile bottlenose dolphin stranded in the eastern North Atlantic Ocean in 2005. Sequence analysis of a conserved fragment of the morbillivirus phosphoprotein gene indicated that the virus is closely related to dolphin morbillivirus recently reported in striped dolphins in the Mediterranean Sea.

        Cite This Article
    EID Sierra E, Zucca D, Arbelo M, García-Álvarez N, Andrada M, Déniz S, et al. Fatal Systemic Morbillivirus Infection in Bottlenose Dolphin, Canary Islands, Spain. Emerg Infect Dis. 2014;20(2):269-271. https://dx.doi.org/10.3201/eid2002.131463
    AMA Sierra E, Zucca D, Arbelo M, et al. Fatal Systemic Morbillivirus Infection in Bottlenose Dolphin, Canary Islands, Spain. Emerging Infectious Diseases. 2014;20(2):269-271. doi:10.3201/eid2002.131463.
    APA Sierra, E., Zucca, D., Arbelo, M., García-Álvarez, N., Andrada, M., Déniz, S....Fernández, A. (2014). Fatal Systemic Morbillivirus Infection in Bottlenose Dolphin, Canary Islands, Spain. Emerging Infectious Diseases, 20(2), 269-271. https://dx.doi.org/10.3201/eid2002.131463.
        Email Email this Article
  • Congenital Rubella Syndrome in Child of Woman without Known Risk Factors, New Jersey, USA PDF Version[PDF - 330 KB - 3 pages]
    S. I. Pitts et al.
        View Abstract

    We report a case of congenital rubella syndrome in a child born to a vaccinated New Jersey woman who had not traveled internationally. Although rubella and congenital rubella syndrome have been eliminated from the United States, clinicians should remain vigilant and immediately notify public health authorities when either is suspected.

        Cite This Article
    EID Pitts SI, Wallace GS, Montana B, Handschur EF, Meislich D, Sampson AC, et al. Congenital Rubella Syndrome in Child of Woman without Known Risk Factors, New Jersey, USA. Emerg Infect Dis. 2014;20(2):307-309. https://dx.doi.org/10.3201/eid2002.131233
    AMA Pitts SI, Wallace GS, Montana B, et al. Congenital Rubella Syndrome in Child of Woman without Known Risk Factors, New Jersey, USA. Emerging Infectious Diseases. 2014;20(2):307-309. doi:10.3201/eid2002.131233.
    APA Pitts, S. I., Wallace, G. S., Montana, B., Handschur, E. F., Meislich, D., Sampson, A. C....Icenogle, J. P. (2014). Congenital Rubella Syndrome in Child of Woman without Known Risk Factors, New Jersey, USA. Emerging Infectious Diseases, 20(2), 307-309. https://dx.doi.org/10.3201/eid2002.131233.
        Email Email this Article
  • Trace-Forward Investigation of Mice in Response to Lymphocytic Choriomeningitis Virus Outbreak PDF Version[PDF - 415 KB - 5 pages]
    L. Edison et al.
        View Abstract

    During follow-up of a 2012 US outbreak of lymphocytic choriomeningitis virus (LCMV), we conducted a trace-forward investigation. LCMV-infected feeder mice originating from a US rodent breeding facility had been distributed to >500 locations in 21 states. All mice from the facility were euthanized, and no additional persons tested positive for LCMV infection.

        Cite This Article
    EID Edison L, Knust B, Petersen B, Gabel J, Manning C, Drenzek C, et al. Trace-Forward Investigation of Mice in Response to Lymphocytic Choriomeningitis Virus Outbreak. Emerg Infect Dis. 2014;20(2):291-295. https://dx.doi.org/10.3201/eid2002.130861
    AMA Edison L, Knust B, Petersen B, et al. Trace-Forward Investigation of Mice in Response to Lymphocytic Choriomeningitis Virus Outbreak. Emerging Infectious Diseases. 2014;20(2):291-295. doi:10.3201/eid2002.130861.
    APA Edison, L., Knust, B., Petersen, B., Gabel, J., Manning, C., Drenzek, C....Nichol, S. T. (2014). Trace-Forward Investigation of Mice in Response to Lymphocytic Choriomeningitis Virus Outbreak. Emerging Infectious Diseases, 20(2), 291-295. https://dx.doi.org/10.3201/eid2002.130861.
        Email Email this Article

Commentaries

Letters

  • Laboratory-acquired Buffalopox Virus Infection, India PDF Version[PDF - 286 KB - 3 pages]
    T. Riyesh et al.
            Cite This Article
    EID Riyesh T, Karuppusamy S, Bera BC, Barua S, Virmani N, Yadav S, et al. Laboratory-acquired Buffalopox Virus Infection, India. Emerg Infect Dis. 2014;20(2):324-326. https://dx.doi.org/10.3201/eid2002.130358
    AMA Riyesh T, Karuppusamy S, Bera BC, et al. Laboratory-acquired Buffalopox Virus Infection, India. Emerging Infectious Diseases. 2014;20(2):324-326. doi:10.3201/eid2002.130358.
    APA Riyesh, T., Karuppusamy, S., Bera, B. C., Barua, S., Virmani, N., Yadav, S....Singh, R. K. (2014). Laboratory-acquired Buffalopox Virus Infection, India. Emerging Infectious Diseases, 20(2), 324-326. https://dx.doi.org/10.3201/eid2002.130358.
        Email Email this Article
  • Avian Influenza A(H7N9) Virus Infection in Pregnant Woman, China, 2013 PDF Version[PDF - 276 KB - 2 pages]
    X. Qi et al.
            Cite This Article
    EID Qi X, Cui L, Xu K, Wu B, Tang F, Bao C, et al. Avian Influenza A(H7N9) Virus Infection in Pregnant Woman, China, 2013. Emerg Infect Dis. 2014;20(2):332-333. https://dx.doi.org/10.3201/eid2002.131109
    AMA Qi X, Cui L, Xu K, et al. Avian Influenza A(H7N9) Virus Infection in Pregnant Woman, China, 2013. Emerging Infectious Diseases. 2014;20(2):332-333. doi:10.3201/eid2002.131109.
    APA Qi, X., Cui, L., Xu, K., Wu, B., Tang, F., Bao, C....Wang, H. (2014). Avian Influenza A(H7N9) Virus Infection in Pregnant Woman, China, 2013. Emerging Infectious Diseases, 20(2), 332-333. https://dx.doi.org/10.3201/eid2002.131109.
        Email Email this Article
  • Stable Transmission of Dirofilaria repens Nematodes, Northern Germany PDF Version[PDF - 368 KB - 3 pages]
    C. Czajka et al.
            Cite This Article
    EID Czajka C, Becker N, Jöst H, Poppert S, Schmidt-Chanasit J, Krüger A, et al. Stable Transmission of Dirofilaria repens Nematodes, Northern Germany. Emerg Infect Dis. 2014;20(2):328-330. https://dx.doi.org/10.3201/eid2002.131003
    AMA Czajka C, Becker N, Jöst H, et al. Stable Transmission of Dirofilaria repens Nematodes, Northern Germany. Emerging Infectious Diseases. 2014;20(2):328-330. doi:10.3201/eid2002.131003.
    APA Czajka, C., Becker, N., Jöst, H., Poppert, S., Schmidt-Chanasit, J., Krüger, A....Tannich, E. (2014). Stable Transmission of Dirofilaria repens Nematodes, Northern Germany. Emerging Infectious Diseases, 20(2), 328-330. https://dx.doi.org/10.3201/eid2002.131003.
        Email Email this Article
  • Peste des Petits Ruminants Virus, Mauritania PDF Version[PDF - 392 KB - 3 pages]
    A. El Arbi et al.
            Cite This Article
    EID El Arbi A, El Mamy A, Salami H, Isselmou E, Kwiatek O, Libeau G, et al. Peste des Petits Ruminants Virus, Mauritania. Emerg Infect Dis. 2014;20(2):333-336. https://dx.doi.org/10.3201/eid2002.131345
    AMA El Arbi A, El Mamy A, Salami H, et al. Peste des Petits Ruminants Virus, Mauritania. Emerging Infectious Diseases. 2014;20(2):333-336. doi:10.3201/eid2002.131345.
    APA El Arbi, A., El Mamy, A., Salami, H., Isselmou, E., Kwiatek, O., Libeau, G....Lancelot, R. (2014). Peste des Petits Ruminants Virus, Mauritania. Emerging Infectious Diseases, 20(2), 333-336. https://dx.doi.org/10.3201/eid2002.131345.
        Email Email this Article
  • Infectious Schmallenberg Virus from Bovine Semen, Germany PDF Version[PDF - 309 KB - 3 pages]
    C. Schulz et al.
            Cite This Article
    EID Schulz C, Wernike K, Beer M, Hoffmann B. Infectious Schmallenberg Virus from Bovine Semen, Germany. Emerg Infect Dis. 2014;20(2):337-339. https://dx.doi.org/10.3201/eid2002.131436
    AMA Schulz C, Wernike K, Beer M, et al. Infectious Schmallenberg Virus from Bovine Semen, Germany. Emerging Infectious Diseases. 2014;20(2):337-339. doi:10.3201/eid2002.131436.
    APA Schulz, C., Wernike, K., Beer, M., & Hoffmann, B. (2014). Infectious Schmallenberg Virus from Bovine Semen, Germany. Emerging Infectious Diseases, 20(2), 337-339. https://dx.doi.org/10.3201/eid2002.131436.
        Email Email this Article
  • Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA PDF Version[PDF - 249 KB - 1 page]
    R. S. Nasci et al.
            Cite This Article
    EID Nasci RS, Brault AC, Lambert AJ, Savage HM. Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA. Emerg Infect Dis. 2014;20(2):336. https://dx.doi.org/10.3201/eid2002.131360
    AMA Nasci RS, Brault AC, Lambert AJ, et al. Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA. Emerging Infectious Diseases. 2014;20(2):336. doi:10.3201/eid2002.131360.
    APA Nasci, R. S., Brault, A. C., Lambert, A. J., & Savage, H. M. (2014). Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA. Emerging Infectious Diseases, 20(2), 336. https://dx.doi.org/10.3201/eid2002.131360.
        Email Email this Article
  • Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA PDF Version[PDF - 257 KB - 2 pages]
    Z. Xing and M. Murtaugh
            Cite This Article
    EID Xing Z, Murtaugh M. Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA. Emerg Infect Dis. 2014;20(2):336-337. https://dx.doi.org/10.3201/eid2002.131790
    AMA Xing Z, Murtaugh M. Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA. Emerging Infectious Diseases. 2014;20(2):336-337. doi:10.3201/eid2002.131790.
    APA Xing, Z., & Murtaugh, M. (2014). Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA. Emerging Infectious Diseases, 20(2), 336-337. https://dx.doi.org/10.3201/eid2002.131790.
        Email Email this Article
  • Nasopharyngeal Bacterial Interactions in Children PDF Version[PDF - 361 KB - 2 pages]
    M. Suzuki et al.
            Cite This Article
    EID Suzuki M, Dhoubhadel B, Yoshida L, Ariyoshi K. Nasopharyngeal Bacterial Interactions in Children. Emerg Infect Dis. 2014;20(2):323-324. https://dx.doi.org/10.3201/eid2002.121724
    AMA Suzuki M, Dhoubhadel B, Yoshida L, et al. Nasopharyngeal Bacterial Interactions in Children. Emerging Infectious Diseases. 2014;20(2):323-324. doi:10.3201/eid2002.121724.
    APA Suzuki, M., Dhoubhadel, B., Yoshida, L., & Ariyoshi, K. (2014). Nasopharyngeal Bacterial Interactions in Children. Emerging Infectious Diseases, 20(2), 323-324. https://dx.doi.org/10.3201/eid2002.121724.
        Email Email this Article
  • NDM-1–producing Strains, Family Enterobacteriaceae, in Hospital, Beijing, China PDF Version[PDF - 762 KB - 3 pages]
    G. Zhou et al.
            Cite This Article
    EID Zhou G, Guo S, Luo Y, Ye L, Song Y, Sun G, et al. NDM-1–producing Strains, Family Enterobacteriaceae, in Hospital, Beijing, China. Emerg Infect Dis. 2014;20(2):340-342. https://dx.doi.org/10.3201/eid2002.131263
    AMA Zhou G, Guo S, Luo Y, et al. NDM-1–producing Strains, Family Enterobacteriaceae, in Hospital, Beijing, China. Emerging Infectious Diseases. 2014;20(2):340-342. doi:10.3201/eid2002.131263.
    APA Zhou, G., Guo, S., Luo, Y., Ye, L., Song, Y., Sun, G....Yang, J. (2014). NDM-1–producing Strains, Family Enterobacteriaceae, in Hospital, Beijing, China. Emerging Infectious Diseases, 20(2), 340-342. https://dx.doi.org/10.3201/eid2002.131263.
        Email Email this Article
  • Nasopharyngeal Bacterial Interactions in Children PDF Version[PDF - 291 KB - 2 pages]
    A. Almudevar
            Cite This Article
    EID Almudevar A. Nasopharyngeal Bacterial Interactions in Children. Emerg Infect Dis. 2014;20(2):339-340. https://dx.doi.org/10.3201/eid2002.131701
    AMA Almudevar A. Nasopharyngeal Bacterial Interactions in Children. Emerging Infectious Diseases. 2014;20(2):339-340. doi:10.3201/eid2002.131701.
    APA Almudevar, A. (2014). Nasopharyngeal Bacterial Interactions in Children. Emerging Infectious Diseases, 20(2), 339-340. https://dx.doi.org/10.3201/eid2002.131701.
        Email Email this Article
  • Recurrence of Animal Rabies, Greece, 2012 PDF Version[PDF - 340 KB - 3 pages]
    K. E. Tasioudi et al.
            Cite This Article
    EID Tasioudi KE, Iliadou P, Agianniotaki EI, Robardet E, Liandris E, Doudounakis S, et al. Recurrence of Animal Rabies, Greece, 2012. Emerg Infect Dis. 2014;20(2):326-328. https://dx.doi.org/10.3201/eid2002.130473
    AMA Tasioudi KE, Iliadou P, Agianniotaki EI, et al. Recurrence of Animal Rabies, Greece, 2012. Emerging Infectious Diseases. 2014;20(2):326-328. doi:10.3201/eid2002.130473.
    APA Tasioudi, K. E., Iliadou, P., Agianniotaki, E. I., Robardet, E., Liandris, E., Doudounakis, S....Mangana-Vougiouka, O. (2014). Recurrence of Animal Rabies, Greece, 2012. Emerging Infectious Diseases, 20(2), 326-328. https://dx.doi.org/10.3201/eid2002.130473.
        Email Email this Article
  • Rabies in Henan Province, China, 2010–2012 PDF Version[PDF - 323 KB - 3 pages]
    G. Li et al.
            Cite This Article
    EID Li G, Qu Z, Lam A, Wang J, Gao F, Deng T, et al. Rabies in Henan Province, China, 2010–2012. Emerg Infect Dis. 2014;20(2):331-332. https://dx.doi.org/10.3201/eid2002.131056
    AMA Li G, Qu Z, Lam A, et al. Rabies in Henan Province, China, 2010–2012. Emerging Infectious Diseases. 2014;20(2):331-332. doi:10.3201/eid2002.131056.
    APA Li, G., Qu, Z., Lam, A., Wang, J., Gao, F., Deng, T....Lu, J. (2014). Rabies in Henan Province, China, 2010–2012. Emerging Infectious Diseases, 20(2), 331-332. https://dx.doi.org/10.3201/eid2002.131056.
        Email Email this Article
  • Injectional Anthrax in Heroin Users, Europe, 2000–2012 PDF Version[PDF - 390 KB - 2 pages]
    M. Hanczaruk et al.
            Cite This Article
    EID Hanczaruk M, Reischl U, Holzmann T, Frangoulidis D, Wagner DM, Keim PS, et al. Injectional Anthrax in Heroin Users, Europe, 2000–2012. Emerg Infect Dis. 2014;20(2):322-323. https://dx.doi.org/10.3201/eid2002.120921
    AMA Hanczaruk M, Reischl U, Holzmann T, et al. Injectional Anthrax in Heroin Users, Europe, 2000–2012. Emerging Infectious Diseases. 2014;20(2):322-323. doi:10.3201/eid2002.120921.
    APA Hanczaruk, M., Reischl, U., Holzmann, T., Frangoulidis, D., Wagner, D. M., Keim, P. S....Grass, G. (2014). Injectional Anthrax in Heroin Users, Europe, 2000–2012. Emerging Infectious Diseases, 20(2), 322-323. https://dx.doi.org/10.3201/eid2002.120921.
        Email Email this Article

Books and Media

About the Cover

  • Seeing Things Differently PDF Version[PDF - 314 KB - 2 pages]
    S. Bloom and A. M. Levitt
            Cite This Article
    EID Bloom S, Levitt AM. Seeing Things Differently. Emerg Infect Dis. 2014;20(2):340-341. https://dx.doi.org/10.3201/eid2002.ac2002
    AMA Bloom S, Levitt AM. Seeing Things Differently. Emerging Infectious Diseases. 2014;20(2):340-341. doi:10.3201/eid2002.ac2002.
    APA Bloom, S., & Levitt, A. M. (2014). Seeing Things Differently. Emerging Infectious Diseases, 20(2), 340-341. https://dx.doi.org/10.3201/eid2002.ac2002.
        Email Email this Article

Etymologia

Online Reports

  • Peer Reviewed Report Available Online Only
    Medscape CME Activity
    Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults
    K. A. Hendricks et al.
        View Abstract

    The Centers for Disease Control and Prevention convened panels of anthrax experts to review and update guidelines for anthrax postexposure prophylaxis and treatment. The panels included civilian and military anthrax experts and clinicians with experience treating anthrax patients. Specialties represented included internal medicine, pediatrics, obstetrics, infectious disease, emergency medicine, critical care, pulmonology, hematology, and nephrology. Panelists discussed recent patients with systemic anthrax; reviews of published, unpublished, and proprietary data regarding antimicrobial drugs and anthrax antitoxins; and critical care measures of potential benefit to patients with anthrax. This article updates antimicrobial postexposure prophylaxis and antimicrobial and antitoxin treatment options and describes potentially beneficial critical care measures for persons with anthrax, including clinical procedures for infected nonpregnant adults. Changes from previous guidelines include an expanded discussion of critical care and clinical procedures and additional antimicrobial choices, including preferred antimicrobial drug treatment for possible anthrax meningitis.

            Email Email this Article
  • Peer Reviewed Report Available Online Only
    Medscape CME Activity
    Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women PDF Version[PDF - 776 KB - 6 pages]
    D. Meaney-Delman et al.
        View Abstract

    In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax.

            Email Email this Article
TOP